The implementation of malaria intermittent preventive trialtreatment with sulphadoxine-pyrimethamine in infants reduced all-cause mortality in the district of Kolokani, Mali: results from a cluster randomized control

The implementation of malaria intermittent preventive trialtreatment with sulphadoxine-pyrimethamine in infants reduced all-cause mortality in the district of Kolokani, Mali: results from a cluster randomized control

<p>Abstract</p> <p>Background</p> <p>Malaria intermittent preventive treatment of malaria in infant with sulphadoxine-pyrimethamine (IPTi-SP) reduced the incidence of malaria and anaemia by 30% and 20% respectively. The strategy is now a recommended policy for malaria c...

Full description

Bibliographic Details
Main Authors:	Dicko Alassane, Konare Moussa, Traore Djibril, Testa Jean, Salamon Roger, Doumbo Ogobara, Rogier Christophe
Format:	Article
Language:	English
Published:	BMC 2012-03-01
Series:	Malaria Journal
Subjects:	Mortality Malaria Intermittent preventive treatment Sulphadoxine-pyrimethamine Expanded programme of immunization
Online Access:	http://www.malariajournal.com/content/11/1/73

Similar Items

Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: Results from a cluster randomized control trial
by: Salomon Roger, et al.
Published: (2011-07-01)

Effects of amodiaquine and artesunate on sulphadoxine-pyrimethamine pharmacokinetic parameters in children under five in Mali
by: Doumbo Ogobara K, et al.
Published: (2011-09-01)

Combination of probenecid-sulphadoxine-pyrimethamine for intermittent preventive treatment in pregnancy
by: Gutman Julie, et al.
Published: (2012-02-01)

Determinants of the uptake of intermittent preventive treatment of malaria in pregnancy with sulphadoxine pyrimethamine in Sabatia Sub County, Western Kenya
by: Joshua A. Mutanyi, et al.
Published: (2021-08-01)

Comparative study of proguanil and sulphadoxine–pyrimethamine in the prevention of malaria in pregnancy
by: Adewale Jamiu Lasisi, et al.
Published: (2018-01-01)

Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study
by: Steven Chifundo Azizi, et al.
Published: (2018-04-01)

Effects of pyrimethamine-sulphadoxine, chloroquine plus chlorpheniramine, and amodiaquine plus pyrimethamine-sulphadoxine on gametocytes during and after treatment of acute, uncomplicated malaria in children
by: A Sowunmi, et al.
Published: (2006-12-01)

Comparative efficacy of artesunate and sulphadoxine-pyrimethamine combination with artesunate and amodiaquine combination in uncomplicated falciparum malaria in children
by: Jose Meky Mandei, et al.
Published: (2008-08-01)

Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015–2016
by: Steven Chifundo Azizi
Published: (2020-03-01)

Antibodies to malaria vaccine candidates are associated with chloroquine or sulphadoxine/pyrimethamine treatment efficacy in children in an endemic area of Burkina Faso
by: Diarra Amidou, et al.
Published: (2012-03-01)

High multiple mutations of Plasmodium falciparum-resistant genotypes to sulphadoxine-pyrimethamine in Lagos, Nigeria
by: Hong Quan, et al.
Published: (2020-07-01)

Genetic polymorphisms associated with sulphadoxine-pyrimethamine drug resistance among Plasmodium falciparum field isolates in malaria endemic areas of Assam
by: J Sharma, et al.
Published: (2015-01-01)

Late ANC initiation and factors associated with sub-optimal uptake of sulphadoxine-pyrimethamine in pregnancy: a preliminary study in Cape Coast Metropolis, Ghana
by: Benjamin Kwasi Amoako, et al.
Published: (2021-02-01)

Comparison of the effectiveness of two-dose versus three-dose sulphadoxine-pyrimethamine in preventing adverse pregnancy outcomes in Nigeria
by: Nneka U Igboeli, et al.
Published: (2018-01-01)

Low coverage of intermittent preventive treatment for malaria in pregnancy in Nigeria: demand-side influences
by: Onoka Chima A, et al.
Published: (2012-03-01)

Molecular characterization of Plasmodium falciparum antifolate resistance markers in Thailand between 2008 and 2016
by: Rungniran Sugaram, et al.
Published: (2020-03-01)

Impact of Community Intermittent Preventive Treatment in Pregnancy (C-IPTp) approach on the uptake of IPTp3+: a randomized controlled trial in Karagwe, Tanzania
by: Alen Kinyina, et al.
Published: (2020-12-01)

An analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina Faso
by: Valea Innocent, et al.
Published: (2012-03-01)

Effect of sulphadoxine-trimethoprim combination on some pharmacokinetic aspects of sulphadoxine in goats
by: H.A.H. Zaghloul, et al.
Published: (2007-06-01)

Drug resistance in malaria
by: Umar Farooq & R.C. Mahajan
Published: (2004-09-01)

Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine–pyrimethamine five dose policy in Ghana
by: Ivy Owusu-Boateng, et al.
Published: (2017-08-01)

Molecular determination of antifolate resistance associated point mutations in Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthetase (dhps) genes among the field samples in Arunachal Pradesh
by: Jitendra Sharma, et al.
Published: (2015-01-01)

Seasonal Malaria Chemoprevention with Sulphadoxine-Pyrimethamine and Amodiaquine Selects Pfdhfr-dhps Quintuple Mutant Genotype in Mali.
by: Hamma Maiga, et al.
Published: (2016-01-01)

Le Traitement Intermittent Préventif comme stratégie de lutte contre le paludisme chez les enfants
by: Dicko, Alassane
Published: (2010)

Sulfadoxine/Pyrimethamine Intermittent Preventive Treatment for Malaria during Pregnancy
by: Philippe Deloron, et al.
Published: (2010-11-01)

Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania
by: Wigilya P. Mikomangwa, et al.
Published: (2020-04-01)

Clinical manifestations of new <it>versus</it> recrudescent malaria infections following anti-malarial drug treatment
by: Shaukat Ayesha M, et al.
Published: (2012-06-01)

Drug resistance associated genetic polymorphisms in <it>Plasmodium falciparum </it>and <it>Plasmodium vivax </it>collected in Honduras, Central America
by: Jovel Irina T, et al.
Published: (2011-12-01)

Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali
by: Coulibaly Oumar M, et al.
Published: (2010-01-01)

Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali
by: Toure Ousmane B, et al.
Published: (2008-07-01)

Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015–2016 Tanzania demographic and health survey and malaria indicator survey
by: Vivian Mushi, et al.
Published: (2021-02-01)

Meta-analysis of intermittent treatment with sulfadoxine-pyrimethamine in pregnancy in malaria endemic areas
by: Mkopi, Abdallah Bakari
Published: (2018)

Intermittent screening and treatment with artemether–lumefantrine versus intermittent preventive treatment with sulfadoxine–pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria
by: Ekpereonne Esu, et al.
Published: (2018-07-01)

Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial
by: Abel Kakuru, et al.
Published: (2020-08-01)

Differences in selective pressure on <it>dhps </it>and <it>dhfr </it>drug resistant mutations in western Kenya
by: McCollum Andrea M, et al.
Published: (2012-03-01)

Artesunate-, sulfadoxine-, and pyrimethamine-induced cardiotoxicity
by: Divya Goel, et al.
Published: (2016-01-01)

Effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine: An in silico pharmacological model
by: Mila Nu Nu Htay, et al.
Published: (2020-01-01)

Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali
by: Traore Boubacar, et al.
Published: (2009-01-01)

Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali
by: Wele Mamadou, et al.
Published: (2009-02-01)

Multicomponent complex formation between pyrimethamine, cyclodextrins and water-soluble polymers
by: Leticia Norma Carpentieri Rodrigues, et al.
Published: (2011-10-01)